威高股份(01066) - 2024 - 中期财报

SUMMARY For the six months ended 30 June 2024 (the "Period"), the unaudited revenue of Shandong Weigao Group Medical Polymer Company Limited (the "Company") and its subsidiaries (the "Group") was approximately RMB6,635,688,000 ( s a m e p e r i o d i n 20 2 3: a p p ro x i m a t e l y RMB6,897,700,000), representing a decrease of approximately 3.8% as compared with the same period last year, the unaudited net profit attributable to the owners of the Company was approximately RMB1,107,549,000 (same period in ...